Cluster of differentiation 133 (CD133) is involved in tumour cell proliferation, metastasis, tumorigenesis or therapy resistance—via activation of the phosphatidylinositol-3-kinase (PI3K)/Akt. The gene discussed is PROM1; the disease is neoplasm.